CVE-2026-123218: IBM Aspera Faspex · Incorrect Authorization
Affects IBM Aspera FaspexSource CVE Database V5
Not known to be exploited · CVSS 9.8 Critical.
Data as of 7 Nov 2026, 04:04 UTC
Thin evidence
One scorer or none| CNA (ibm) | CVSS 3.1 | 9.8 |
|---|
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 7 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 6 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMAspera Faspex | Affected
| Fixed in– |
AI-suggested
Until an official fix is available, restrict access to IBM Aspera Faspex installations to trusted users only and monitor for suspicious activity related to privilege escalation attempts.
Description
IBM Aspera Faspex versions 5.0.0 through 5.0.19 contain an authorization vulnerability that allows an authorized user to bypass normal user restrictions and gain full administrative privileges. This flaw is classified as CWE-863 (Incorrect Authorization) and has a critical severity rating with a CVSS score of 9.8.